Teladoc Health, Inc.
TDOC- Exchange
- NYSE
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- SEC CIK
- 0001477449
In the last 90 days, Teladoc Health, Inc. insiders filed 0 open-market purchases and 9 sales; 347 institutions reported holding it in 13F filings for Q2 2026, worth $1.29B in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Teladoc Health, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 9 filings
- 6 insiders, $486.9K in total
- Insiders trading
- 6
- Net value
- −$486.9K
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Teladoc Health, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Divita Charles III | CHIEF EXECUTIVE OFFICER | 465,535 | Sep 14, 2026 | 7 |
| Nueno Carlos | President, International | 64,744 | Sep 3, 2026 | 4 |
| Vandervoort Adam C | CHIEF LEGAL OFFICER, SECRETARY | 117,616 | Sep 3, 2026 | 4 |
| Bliss Kelly | President, U.S. Group Health | 92,832 | Sep 3, 2026 | 7 |
| Catapano Joseph Ronald | Chief Accounting Officer | 12,865 | Sep 3, 2026 | 7 |
| Rodrigues Fernando M. | President of BetterHelp | 0 | Sep 3, 2026 | 5 |
| Grasher Michael F | Chief Financial Officer | – | Sep 1, 2026 | 1 |
| Anquillare Mark V | Director | – | Aug 4, 2026 | 1 |
| Shedlarz David L | Director | 61,266 | May 21, 2026 | 1 |
| Snow David B Jr | Director | 113,032 | May 21, 2026 | 1 |
| Fenwick Sandra L | Director | 12,070 | May 21, 2026 | 1 |
| Paulus Kenneth H | Director | 10,000 | May 21, 2026 | 2 |
| Smith Mark Douglas | Director | 8,355 | May 21, 2026 | 1 |
| Jacobson Catherine | Director | 66,853 | May 21, 2026 | 1 |
| Salka Susan R | Director | – | Apr 1, 2026 | 1 |
| Smith Michael S | Director | – | Feb 19, 2026 | 1 |
| Evans Jason Eric | Director | 9,145 | Dec 22, 2025 | 1 |
| Murthy Mala | CHIEF FINANCIAL OFFICER | 142,385 | Sep 3, 2025 | 0 |
| McKinley Thomas | Director | 56,544 | May 23, 2025 | 0 |
| Turitz Andrew | EVP, CORPORATE DEVELOPMENT | 20,773 | Sep 5, 2024 | 0 |
| Raman-Tangella Vidya | CHIEF MEDICAL OFFICER | 33,665 | Sep 5, 2024 | 0 |
| Verstraete Stephany | CHIEF MARKETING OFFICER | 48,843 | Sep 4, 2024 | 0 |
| Trencher Daniel | CHIEF STRATEGY OFFICER | 31,465 | Sep 4, 2024 | 0 |
| Geshuri Arnnon | CHIEF PEOPLE OFFICER | 44,914 | Sep 4, 2024 | 0 |
| Waters Michael Willem | CHIEF OPERATING OFFICER | 78,309 | Sep 4, 2024 | 0 |
| Nanis Nikolaos P. | Chief Technology Officer | 75,410 | Sep 4, 2024 | 0 |
| Cave James L. | INTERIM CAO | 13,808 | Sep 4, 2024 | 0 |
| Kornwasser Laizer | Advisor to the CEO | 99,929 | Aug 5, 2024 | 0 |
| Daniel Karen L | Director | 36,995 | May 24, 2024 | 0 |
| Gorevic Jason N | CHIEF EXECUTIVE OFFICER | 653,073 | Mar 20, 2024 | 0 |
| Napolitano Richard J | CHIEF ACCOUNTING OFFICER | 18,077 | Mar 20, 2024 | 0 |
| Jensen Claus Torp | CHIEF INNOVATION OFFICER | 20,703 | Dec 5, 2023 | 0 |
| Frist William H. | Director | 12,918 | May 31, 2022 | 0 |
| Bischoff Christopher | Director | 7,195 | May 18, 2022 | 0 |
| Sides David William | Chief Operating Officer | 11,031 | Aug 2, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 3, 2026 (view filing)4:05 PM ET | Sep 2 | 1 day | Bliss KellyPresident, U.S. Group Health | SSale | −7.36K | $6.30 | −$46.4K | −7.3%92.8K after | |
| Sep 3, 2026 (view filing)4:05 PM ET | Sep 2 | 1 day | Vandervoort Adam CCHIEF LEGAL OFFICER, SECRETARY | SSale | −7.57K | $6.30 | −$47.7K | −6.0%117.6K after | |
| Sep 3, 2026 (view filing)4:06 PM ET | Sep 2 | 1 day | Nueno CarlosPresident, International | SSale | −6.20K | $6.30 | −$39.1K | −8.7%64.7K after | |
| Sep 14, 2026 (view filing)4:05 PM ET | Sep 11 | 3 days | Divita Charles IIICHIEF EXECUTIVE OFFICER | SSale | −17.8K | $6.10 | −$108.7K | −3.7%465.5K after |